Literature DB >> 17630411

National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine practice guidelines: Analytical issues for biomarkers of heart failure.

Fred S Apple1, Alan H B Wu, Allan S Jaffe, Mauro Panteghini, Robert H Christenson, Christopher P Cannon, Gary Francis, Robert L Jesse, David A Morrow, L Kristen Newby, Alan B Storrow, W H Wilson Tang, Franca Pagani, Jillian Tate, Jordi Ordonez-Llanos, Johannes Mair.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17630411     DOI： 10.1161/CIRCULATIONAHA.107.185266

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  16 in total

1.  Identifying biomarker patterns and predictors of inflammation and myocardial stress.

Authors:  Ruth M Masterson Creber; Christopher S Lee; Kenneth Margulies; Barbara Riegel
Journal:  J Card Fail       Date:  2015-02-26       Impact factor: 5.712

2.  National Academy of Clinical Biochemistry (NACB) laboratory medicine guidelines on the clinical utilization and analytical issues for cardiac biomarker testing in heart failure.

Authors:  John Beilby
Journal:  Clin Biochem Rev       Date:  2008-08

3.  Can plasma levels of N-terminal pro-brain natriuretic peptide be useful in predicting the risk of developing chronic pulmonary hypertension in patients with pulmonary embolism?

Authors:  Federico Lussana; Gian Marco Podda; Marco Cattaneo
Journal:  Intern Emerg Med       Date:  2009-08-05       Impact factor: 3.397

Review 4.  The paradox of low BNP levels in obesity.

Authors:  Aldo Clerico; Alberto Giannoni; Simona Vittorini; Michele Emdin
Journal:  Heart Fail Rev       Date:  2012-01       Impact factor: 4.214

5.  Cardiac troponin T elevations, using highly sensitive assay, in recreational running depend on running distance.

Authors:  Alma M A Mingels; Leo H J Jacobs; Vincent W Kleijnen; Eduard M Laufer; Bjorn Winkens; Leonard Hofstra; Will K W H Wodzig; Marja P van Dieijen-Visser
Journal:  Clin Res Cardiol       Date:  2010-03-08       Impact factor: 5.460

6.  Background and design of the profiling biobehavioral responses to mechanical support in advanced heart failure study.

Authors:  Christopher S Lee; James O Mudd; Jill M Gelow; Thuan Nguyen; Shirin O Hiatt; Jennifer K Green; Quin E Denfeld; Julie T Bidwell; Kathleen L Grady
Journal:  J Cardiovasc Nurs       Date:  2014 Sep-Oct       Impact factor: 2.083

7.  Biomarkers of myocardial stress and systemic inflammation in patients who engage in heart failure self-care management.

Authors:  Christopher S Lee; Debra K Moser; Terry A Lennie; Nancy C Tkacs; Kenneth B Margulies; Barbara Riegel
Journal:  J Cardiovasc Nurs       Date:  2011 Jul-Aug       Impact factor: 2.083

Review 8.  Programmable bio-nanochip technology for the diagnosis of cardiovascular disease at the point-of-care.

Authors:  Nicolaos Christodoulides; Floriano N Pierre; Ximena Sanchez; Luanyi Li; Kyle Hocquard; Aaron Patton; Rachna Muldoon; Craig S Miller; Jeffrey L Ebersole; Spencer Redding; Chih-Ko Yeh; Wieslaw B Furmaga; David A Wampler; Biykem Bozkurt; Christie M Ballantyne; John T McDevitt
Journal:  Methodist Debakey Cardiovasc J       Date:  2012-01

Review 9.  The expanding role of biomarkers in the assessment of smoking-related parenchymal lung diseases.

Authors:  Tracy J Doyle; Victor Pinto-Plata; Danielle Morse; Bartolome R Celli; Ivan O Rosas
Journal:  Chest       Date:  2012-10       Impact factor: 9.410

10.  Correlates of NT-proBNP concentration in patients with essential hypertension in absence of congestive heart failure.

Authors:  Keizo Toda; Yukihito Sato; Tomoko Hara; Kenro Hijiya; Ryutaro Kaneko; Tatuo Okada; Yoshiki Takatsu; Hisayoshi Fujiwara; Toshiaki Iwasaki
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.